跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“CHEMOSAT”
全部
39
临床试验
19
药物
4
机构
3
资讯
13
去年
Delcath's Hepzato Kit Trials in Liver-Dominant Metastatic Colorectal Cancer Following FDA Clearance
2个月前
Delcath Systems Doses First Patient in Phase 2 DELUMA Trial of HEPZATO for Liver-Dominant Metastatic Breast Cancer
去年
Delcath Systems Reports Strong Q3 2024 Growth Driven by HEPZATO Kit Sales
去年
FDA Clears Delcath's HEPZATO for Phase 2 Trial in Liver-Dominant Metastatic Breast Cancer
2个月前
Routine Eye Tests Lead to Rare Uveal Melanoma Diagnoses, Highlighting Access Gap for Life-Extending Chemosaturation Therapy in the UK
去年
Chemomab Announces Positive CM-101 Phase 2 Trial Results and Outlines Phase 3 Plans for Primary Sclerosing Cholangitis
去年
Chemomab Therapeutics to Present CM-101 Data at Upcoming Investor Conferences
去年
Cocrystal Pharma and Chemomab Therapeutics Report Progress in Antiviral and Fibro-inflammatory Drug Development
去年
AbbVie's Vyalev for Parkinson's Disease Incorporates Key Innovations from KU Chemist
2年前
Chemomab Secures Global Patent Protection for CM-101 Antibody Targeting Primary Sclerosing Cholangitis
第 1 页,共 2 页
上一页
下一页